ORLANDO, Fla.–(BUSINESS WIRE)–20/20 Onsite, Boston-based mobile optometry company, is excited to announce their expansion to Florida, now offering their leading on-site vision care services to Orlando employers. 20/20 Onsite has been providing on-sit…
Author: Business Wire
Join Google, Regeneron, Scientific American, PPD-Thermo Fisher, and Top-Tier VCs, Members of the Media, and Public and Private Biotechs Exploring the Big Questions in Health and Bio at the BioFuture™ Conference
NEW YORK–(BUSINESS WIRE)– #biofuture2023–Join top-tier therapeutic innovators, journalists and investors Oct. 4-6 to shape the future of bioscience. Register for BioFuture™ now!
Bausch + Lomb’s ONE by ONE and Biotrue® Eye Care Recycling Programs Recognized As Sustainability Service of the Year Award Winners
VAUGHAN, Ontario–(BUSINESS WIRE)–Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced its ONE by ONE and Biotrue Eye Care Recycling programs have been r…
Weave Delivers Over 1.8 Billion Unique Customer Interactions
LEHI, Utah–(BUSINESS WIRE)–Weave (NYSE: WEAV), a leading all-in-one experience platform for small and medium-sized healthcare practices, announced today that its 27,000+ customers used Weave’s platform to interact with their patients more than 1.8 bi…
OcuTerra President and CEO Kerrie Brady Named to 2023 PharmaVoice 100 List of Most Inspiring Leaders
BOSTON–(BUSINESS WIRE)–OcuTerra Therapeutics announces President and CEO Kerrie Brady has been named to this year’s PharmaVoice 100 list.
Precision Fermentation Fuels Growth in Ophthalmic Viscoelastic Devices Market: Opportunities and Key Segments – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Ophthalmic Viscoelastic Devices Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures, and Forecast to 2033” report has been added to ResearchAndMa…
Bausch + Lomb Announces Pricing of Senior Secured Notes Offering
VAUGHAN, Ontario–(BUSINESS WIRE)–Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced that Bausch + Lomb Escrow Corp. (“Escrow Issuer”), a wholly owned …
Insightful Analysis of US Contact Lenses Market: Corrective Lenses and Spherical Designs Propel Growth – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “US Contact Lenses Market – Focused Insights 2023-2028” report has been added to ResearchAndMarkets.com’s offering. The US contact lenses market is poised for significant growth, projected to reach $4.38 billion in 2028 fro…
NovaBay Pharmaceuticals Announces Commercial Launch of Avenova® Allograft
EMERYVILLE, Calif. & POMPANO BEACH, Fla.–(BUSINESS WIRE)–NovaBay Pharmaceuticals, Inc. (NYSE American: NBY) announces the commercial launch of Avenova Allograft to eyecare professionals across the U.S. through its physician-dispensed channel. This pr…
STAAR Surgical to Ring Nasdaq Stock Market Closing Bell Following Vision 2026 Investor Day on September 14, 2023
LAKE FOREST, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses for the eye, will host Vision 2026, the Company’s investor day, at the Nasdaq MarketSite in Times Square t…
Revolutionizing Vision Care: Global Artificial Retina Market Grows Amid Rising Prevalence of Retinal Diseases – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Artificial Retina Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts – 2023 to 2031” report has been added to ResearchAndMarkets.com’s offeri…
Character Biosciences Strengthens Leadership Team with Appointment of Laura Carter, Ph.D. as Chief Scientific Officer
SAN FRANCISCO–(BUSINESS WIRE)–Character Biosciences, a drug discovery and development company leveraging human genetics and medical imaging-based machine learning to target disease progression, today announced the appointment of Laura Carter, Ph.D. a…
RG6501 (OpRegen®) Phase 1/2a Additional Results to Be Featured at 23rd EURETINA Congress
CARLSBAD, Calif.–(BUSINESS WIRE)—- $LCTX #LineageCellTherapeutics–Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, today announced t…
Alex Gorsky Joins Neurotech’s Board as Lead Director
CUMBERLAND, R.I.–(BUSINESS WIRE)–Neurotech Pharmaceuticals, Inc., a private clinical stage biotech company, announced today that Alex Gorsky has been elected to Neurotech’s board as Lead Director. Gorsky is the former Chairman and CEO of Johnson &…
Veero® Brings Its Powerful Eyewear Fit-Optimization Technology to Brick-and-Mortar Retail and Optical Stores with New Veero EyeSize IRL
BOSTON–(BUSINESS WIRE)–AI-software innovator Veero® today introduced Veero EyeSize IRL, a new eyewear shopping technology that optimizes frame recommendations and as-worn measures by capturing customers’ precise facial measurements in the store. EyeS…
The Retina Center of St. Louis County Applauds Data Confirming Dietary Oral Zeaxanthin Decreases the Progression of Wet Age-Related Macular Degeneration
ST LOUIS–(BUSINESS WIRE)–The Retina Center of St. Louis County is excited to share recent data that was published in the peer-reviewed journal Ophthalmology and Therapy, titled Prevention Surpasses Treatment: 5-year Follow-Up, Cost-Utility, and Cost-…
NTT Introduces Revolutionary Optical Power Supply for High-Speed Communications
TOKYO–(BUSINESS WIRE)– #TechforGood–NTT and the Kitami Institute of Technology improved power outage recovery time by delivering electrical power through optical communication lines.
Bausch + Lomb Launches MIEBO™ (Perfluorohexyloctane Ophthalmic Solution) in the United States
VAUGHAN, Ontario–(BUSINESS WIRE)–Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced the U.S. commercial launch of MIEBO (perfluorohexyloctane ophthalm…
Oxular Announces Appointment of Mark Gaffney as Chief Executive Officer
OXFORD, United Kingdom & CAMBRIDGE, Mass.–(BUSINESS WIRE)–Oxular Limited, a clinical-stage ophthalmic company developing long-lasting targeted treatments for retinal disorders to improve patients’ vision, today announces that Mark Gaffney has been ap…
Lassen Therapeutics Presents New Data on LASN01 for the Treatment of Idiopathic Pulmonary Fibrosis and Thyroid Eye Disease at the European Respiratory Society (ERS) and European Thyroid Association (ETA) Annual Meetings
SAN DIEGO–(BUSINESS WIRE)–Lassen Therapeutics, a clinical stage biotech company developing first-in-class antibody therapeutics targeting interleukin-11 receptor (IL-11R, LASN01) as a potential treatment for fibro-inflammatory diseases including thyr…